Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.04.28
关于公司关联方占用上市公司资金情形的专项审核报告
2015.04.28
未来三年(2015-2017年)股东分红回报妄想
2015.04.28
内部控制规则落实自查表
2015.04.28
关于向银行申请授信的通告
2015.04.28
关于开展2015年远期外汇生意情形的通告
2015.04.28
关于全资子公司使用自用资金对Rapid Micro Biosystems, Inc.举行投资的通告
2015.04.23
关于全资子公司使用自有资金对CANTEX举行投资的完成通告
2015.04.17
关于全资子公司使用自有资金对CDH Avatar,L.P.举行投资的希望通告
2015.04.14
关于设立工业并购基金的希望通告
2015.04.08
第三届董事会第九次聚会决议通告
第一页
上一页
103
104
105
106
107
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】